today announced that a study in health economics and outcomes research focused on the cost and clinical burden in people suffering with hereditary hemorrhagic telangiectasia (HHT) will be presented at ...

There is a significant number of debilitating and largely untreated rare diseases, such as HHT (Hereditary Haemorrhagic Telangiectasia), in which patients have overactivation of AKT triggered by ...

Kumaraguru Raja, an analyst from Brookline Capital Markets, has initiated a new Buy rating on Quince Therapeutics (QNCX).Pick the best stocks ...